EP Patent

EP2327409A1 — Tetracycline compound having target therapeutic activities

Assigned to Paratek Pharmaceuticals Inc · Expires 2011-06-01 · 15y expired

What this patent protects

New tetracycline compound having a target therapeutic activity are described. The compound has the following formula:

USPTO Abstract

New tetracycline compound having a target therapeutic activity are described. The compound has the following formula:

Drugs covered by this patent

Patent Metadata

Patent number
EP2327409A1
Jurisdiction
EP
Classification
—
Expires
2011-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Paratek Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.